Stay updated on CD19/22 CAR T Cells in DLBCL Clinical Trial
Sign up to get notified when there's something new on the CD19/22 CAR T Cells in DLBCL Clinical Trial page.

Latest updates to the CD19/22 CAR T Cells in DLBCL Clinical Trial page
- Check5 days agoChange DetectedThe study page now renders a 403 Forbidden error page with a header and a Home button, replacing the detailed study information. This indicates the study record is currently inaccessible on ClinicalTrials.gov.SummaryDifference20%

- Check12 days agoChange DetectedThe page shows a revision tag updated from v3.6.6 to v3.7.0. This reflects a backend/template upgrade rather than changes to the study details or user-facing content.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a new release of the page. This likely reflects minor fixes or template updates rather than changes to the study data or narrative.SummaryDifference0.0%

- Check33 days agoChange DetectedAn additional funding/contract line was added to the study's identifiers, updating the metadata attached to the trial. This signals new funding attribution within the study record but does not alter the study design, eligibility, or reported results.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page revision was updated to v3.6.5 from v3.6.4. This marks a new version of the page.SummaryDifference0.0%

- Check62 days agoChange DetectedA new site revision label 'Revision: v3.6.4' was added and the previous label 'Revision: v3.6.3' was removed, indicating a software update to the page.SummaryDifference0.0%

Stay in the know with updates to CD19/22 CAR T Cells in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/22 CAR T Cells in DLBCL Clinical Trial page.